Iterum Therapeutics plc Ordinary Share (ITRM) Stock Price, Quote & AI Analysis

Live ITRM stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Iterum Therapeutics plc Ordinary Share.

TradeVae provides AI-driven analysis and real-time market intelligence for Iterum Therapeutics plc Ordinary Share (ITRM), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

ITRM
Iterum Therapeutics plc Ordinary Share
real-time
$0.00 +0.00 (+0.00%)
Market Cap
$16,360,514.45
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Aug 3, 2026 Q2
Market
EPS Estimate: $-0.102
Revenue Estimate: $1,964,520.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Iterum Therapeutics plc Ordinary Share's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Iterum Therapeutics plc Ordinary Share Overview

Company information

Company Overview

Company description not available

Company Details
Market Cap
$16.36M
Weighted Shares Outstanding
53,291,578
Address
3 DUBLIN LANDINGS, DUBLIN 1, L2, D01 H104
Employees
9
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Iterum Therapeutics plc Ordinary Share Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...